Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1878825 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL8420 | 1.00 | — | — | |
| SCHEMBL629331 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL158879 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL8462 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL1874289 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL2187 | 1.00 | — | — | |
| SCHEMBL3056 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL284790 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA | |
| SCHEMBL199711 | 1.00 | TSHR (0.61) | TSHRTHRBDNM1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 679 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030852-B2 | Method for producing fatty alcohol esters of hydroxycarboxylic acids | IOI OLEO GMBH (DE) | 2024-07-09 | — | — | US | claimed |
| CN-113993833-B | Method for producing acyl-terminated 3-hydroxycarboxylic acid and salts and esters thereof | 凯托利皮克斯治疗有限责任公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117460996-A | Composition for removing photoresist from substrate and use thereof | 弗萨姆材料美国有限责任公司 | 2024-01-26 | — | — | CN | claimed |
| US-20230226087-A1 | PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS | ANDREAS HETTICH GMBH & CO. KG (DE) | 2023-07-20 | — | — | US | claimed |
| WO-2023099241-A1 | AQUEOUS CARE AND/OR MAKEUP COMPOSITION COMPRISING A FATTY ACID MONOESTER, A NEUTRALIZED ANIONIC SURFACTANT, A VP/EICOSENE COPOLYMER, A SEMICRYSTALLINE POLYMER AND A LATEX | L'OREAL (FR) | 2023-06-08 | — | — | WO | claimed |
| US-20230159430-A1 | METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS | IOI OLEO GMBH (DE) | 2023-05-25 | — | — | US | claimed |
| EP-4135714-A1 | PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS | Andreas Hettich GmbH & Co. KG (DE) | 2023-02-22 | — | — | EP | claimed |
| EP-3956282-A1 | PROCESS FOR PREPARING ACYL-CAPPED 3-HYDROXYCARBOXYLIC ACIDS AND THEIR SALTS AND ESTERS | IOI Oleo GmbH (DE) | 2022-02-23 | — | — | EP | claimed |
| CN-113993833-A | Process for producing acyl-terminated 3-hydroxycarboxylic acids and salts and esters thereof | IOI油脂化学品有限责任公司 | 2022-01-28 | — | — | CN | claimed |
| EP-3897519-A1 | COSMETIC COMPOSITION FOR KERATIN FIBERS COMPRISING C14-20 FATTY ACID AND SEMICRYSTALLINE POLYMER | L'OREAL (FR) | 2021-10-27 | — | — | EP | claimed |
| WO-2011133072-A1 | ARRANGEMENT FOR OPERATING A HYDRAULIC DEVICE | PARKER HANNIFIN AB (SE) | 2011-10-27 | — | — | WO | claimed |
| WO-2011008636-A1 | 3-OXY-HYDROMORPHONE DERIVATIVES | MALLINCKRODT INC. (US) | 2011-01-20 | — | — | WO | claimed |
| US-20110015398-A1 | 3-Oxy-Hydromorphone Derivatives | MALLINCKRODT INC. (US) | 2011-01-20 | — | — | US | claimed |
| WO-2010118415-A1 | UV PROTECTING COMPOSITION AND METHODS OF USE | L'OREAL (FR) | 2010-10-14 | — | — | WO | claimed |
| US-20090041691-A1 | Sun protection compositions comprising semi-crystalline polymers and hollow latex particles | L'OREAL (FR) | 2009-02-12 | — | — | US | claimed |
| US-7175818-B2 | Extraction of metals with diquaternary ammonium salts | LYNNTECH, INC. (US) | 2007-02-13 | — | — | US | claimed |
| US-20050261159-A1 | Detergent composition comprising at least one semi-crystalline polymer and at least one oil | L'OREAL S.A. (FR) | 2005-11-24 | — | — | US | claimed |
| US-20050169865-A1 | Cosmetic composition comprising at least one cationic agent, at least one semi-crystalline polymer and at least one oil, and cosmetic treatment process | L'OREAL S.A. (FR) | 2005-08-04 | — | — | US | claimed |
| CN-1356160-A | Cationic quaternary surfactant and its preparing process | CHINA PETROCHEMICAL CORP (CN) | 2002-07-03 | — | — | CN | claimed |
| EP-0040039-B1 | ETHYLENE GLYCOL DERIVATIVES OF AMMONIOETHYL PHOSPHATE, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1984-08-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030852-B2 | Method for producing fatty alcohol esters of hydroxycarboxylic acids | FASN, HSD17B12, SCD | TSHR 2979/4885THRB 1101/4885DNM1 3492/4885 |
| US-20110015398-A1 | 3-Oxy-Hydromorphone Derivatives | OPRD1, OPRK1, OPRM1 | TSHR 1736/4885THRB 774/4885DNM1 3520/4885 |
| US-20090041691-A1 | Sun protection compositions comprising semi-crystalline polymers and hollow latex particles | CTSA, CUTA, MCM7 | TSHR 4707/4885THRB 4552/4885DNM1 4469/4885 |
| US-20230226087-A1 | PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS | PHOSPHO1, SGMS2, SGMS1 | TSHR 2649/4885THRB 2513/4885DNM1 2082/4885 |
| US-20230159430-A1 | METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS | FASN, HSD17B12, SCD | TSHR 2979/4885THRB 1101/4885DNM1 3492/4885 |
| US-20050169865-A1 | Cosmetic composition comprising at least one cationic agent, at least one semi-crystalline polymer and at least one oil, and cosmetic treatment process | KRT18, CUTA, MITF | TSHR 2772/4885THRB 3436/4885DNM1 2987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.